Definition
The Crédit d’Impôt Recherche (CIR) is France’s R&D tax credit — one of the most generous in the world. Companies conducting eligible R&D activities in France can deduct 30% of qualifying R&D expenditure from their corporate tax bill, on the first €100 million of annual R&D spend. Above €100 million, the rate drops to 5%. The CIR covers personnel costs of researchers and engineers, depreciation of R&D equipment, patent costs, and subcontracted research. It is available to all companies — French and foreign — conducting R&D in France, making it a critical component of France’s foreign investment attraction strategy.
Role in France 2030
The CIR and France 2030 are the two pillars of France’s innovation funding architecture, operating through fundamentally different mechanisms. France 2030 provides direct grants and equity for specific strategic projects. The CIR provides a universal, rules-based tax credit for any qualifying R&D activity. Together, they create a layered support structure: a company can receive France 2030 funding for a specific project and simultaneously claim the CIR on the personnel and equipment costs of that project’s R&D phase.
For France 2030’s mission to build competitive industrial champions, the CIR is the structural underpinning that makes France a globally competitive R&D location. A semiconductor company investing in advanced chip R&D in Crolles, a pharmaceutical company running clinical trials in Lyon, or an AI startup employing research engineers in Paris all benefit from the same CIR mechanism — regardless of whether they have won a specific France 2030 competition. This universality ensures that France 2030’s targeted investments occur within an R&D environment that is globally cost-competitive.
The CIR is France’s single most expensive tax expenditure, costing approximately €7–8 billion annually. It has been repeatedly challenged by budget hawks as poorly targeted and susceptible to abuse by large companies conducting incremental R&D rather than genuine innovation. But its political durability — it has survived every budget crisis since its significant expansion in 2008 — reflects France’s cross-partisan consensus that maintaining R&D attractiveness is non-negotiable.
Key Facts
- Rate: 30% on first €100 million of eligible R&D expenditure; 5% above €100 million
- Available to all companies conducting eligible R&D in France (domestic and foreign)
- Annual cost to French public finances: approximately €7–8 billion
- Eligible expenditure: personnel (researchers and technicians), equipment depreciation, patent costs, subcontracted research (with additional benefit for public lab subcontracting)
- Can be combined with France 2030 grants on the same projects
- Refundable for startups: startups can claim the credit as a cash refund rather than waiting for tax liability
- Administered by Ministry of Research with tax authority oversight
Why It Matters
For any company making an R&D investment decision — whether to locate research activities in France, Germany, the UK, or the US — the CIR is a primary financial input. A company spending €50 million annually on R&D in France receives €15 million back through the CIR, every year, as a reliable entitlement rather than a discretionary grant. This is not project-specific support; it is a permanent, universal cost reduction for R&D in France.
Combined with France 2030’s project-specific grants, the total French public support for qualifying R&D investments can reach 60–70% of project costs in the most favorable scenarios. No other major European country matches this combination of universal tax credit and sector-specific grant support. It is a primary reason why major multinationals — STMicroelectronics, GlobalFoundries, Airbus, Sanofi — have chosen to expand R&D capacity in France rather than elsewhere in Europe.